1. Home
  2. /
  3. Venture Capital
  4. /
  5. Amyl Therapeutics receives additional...

News / Venture Capital

Amyl Therapeutics receives additional €5M funding to advance therapeutic platform

8 November 2023
Investor base strengthened by Mr Evren Ucok joining as new shareholder and continued support from historical investors Financing will be used to accelerate development of Amyl technology platform to treat neurodegenerative diseases and AL amyloidosis

Download

Press Release
Download

Related News

arrow-up-right
arrow-up-right
arrow-up-right